Li, C., Shen, H., Liu, Y., Zhao, T., Li, C. (2026). Adjuvant donafenib plus anti–PD-1 therapy in hepatocellular carcinoma with high-risk features after curative resection: A real-world study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16254